您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical composition with improved bioavailability
专利权人:
F. HOFFMANN-LA ROCHE AG
发明人:
Sandhu, Harpreet K.,Shah, Navnit Hargovindas,Lomuscio, Steve,Ma, Hua,Matchett, Michael Allen,Zhang, Yu-E
申请号:
NZ70827214
公开号:
NZ708272A
申请日:
2014.01.20
申请国别(地区):
NZ
年份:
2020
代理人:
摘要:
The invention relates to solid dispersions of poorly water soluble compounds, in particular 4-{ [(2R,3S,4R,5S)-4-(4-chloro-2-fluorophenyl)-3-(3-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-pyrrolidine-2-carbonyl]amino} -3-methoxy-benzoic acid, formed by solvent co-precipitation or spray drying with a stabilising polymer, resulting in improved bioavailability, safety and tolerability of said compounds, and where in the stabilising polymer is poly(methacrylic acid)-co-methyl methacrylate (EUDRAGITR L-100), poly(methacrylic acid)-co-methyl methacrylate (Eudragit L100-55) or poly(vinylpyrrolidone-co-vinyl acetate) (6+4).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充